Hippo Holdings Inc. filings document formal disclosures for a NYSE-listed insurance technology company with common stock trading under HIPO. Recent Form 8-K reports furnish quarterly and annual operating results, investor presentations, supplemental financial information, and reconciliations of non-GAAP measures to GAAP measures.
The company’s proxy filings cover annual meeting materials, stockholder voting matters, board governance, and public-company disclosure requirements. Together, the filing record emphasizes Hippo’s insurance-platform performance, premium and underwriting metrics, capital and equity disclosures, and governance framework.
Hippo Holdings Inc. (HIPO) reported a director’s equity award on a Form 4. On 10/01/2025, the reporting person acquired 2,502 shares of Common Stock via restricted stock units (RSUs) at $0.00 per unit.
The RSUs vest in full upon the earlier of the first anniversary of the grant date or immediately prior to the Annual Meeting following the grant, subject to continued service. Following the reported transaction, the reporting person beneficially owned 2,502 shares, held as direct ownership.
Hippo Holdings (HIPO) reported a Form 3 for director Susan Claire Holliday, effective 10/01/2025. The filing states that no securities are beneficially owned. This is an initial statement under Section 16 and was filed by one reporting person.
Hippo Holdings Inc. (HIPO) Form 3 filed for Laura J. Hay, who is identified as a Director. The event date triggering the filing is 10/01/2025. The filing states that no securities are beneficially owned by the reporting person as of the event date. The form was signed by Guy Zeltser, Attorney-in-Fact on 10/03/2025.
Hippo Holdings Inc. insider Guy Zeltser, the company's Chief Financial Officer, reported sales of common stock on 09/17/2025 executed under a Rule 10b5-1 trading plan dated June 18, 2025. The Form 4 shows two sale line items totaling 5,177 shares sold at weighted average prices of $37.4569 and $38.045, leaving the reporting person with 74,861 shares beneficially owned after the transactions.
The filing notes that the remaining holdings include 65,817 RSUs. The reporting person certified the sales and provided undertakings to supply trade-level details on request.
Hippo Holdings Inc. (HIPOW) submitted a Form 144 disclosing a proposed sale of 5,177 common shares by a person for whose account the securities are to be sold. The shares have an aggregate market value of $192,636.17 based on the filing, against 25,028,054 shares outstanding. The proposed approximate sale date is 09/17/2025 on the NYSE. The shares were acquired from the issuer as restricted stock units on 02/15/2025 and were paid in full on that date. The filer reports no securities sold in the past three months for the account.
Michael Stienstra, an officer of Hippo Holdings Inc. (HIPO), reported a change in beneficial ownership on a Form 4 related to a transaction dated 09/10/2025. The filing shows a disposition of 752 shares of Hippo common stock at a price of $36.97 each. After the reported transaction, Mr. Stienstra beneficially owns 77,644 shares, which the filing states includes 44,246 RSUs. The Form 4 was signed by an attorney-in-fact, Guy Zeltser, on 09/11/2025. No additional transactions, derivative holdings, or explanatory details beyond the RSU component are provided in the text.
Torben Ostergaard, listed as an officer (CEO Spinnaker) of Hippo Holdings Inc. (HIPO), reported a sale of common stock on 09/10/2025. The Form 4 shows 1,358 shares disposed at a price of $36.97 per share, reducing his direct holdings to 60,975 shares after the transaction. The filing notes those holdings include 52,671 RSUs, and the form was signed on behalf of Mr. Ostergaard by an attorney-in-fact, Guy Zeltser, on 09/11/2025.
The report is a standard Section 16 disclosure of an insider sale and provides explicit details on the number of shares sold, sale price, and resulting beneficial ownership. No derivative transactions or additional material terms are reported in this filing.
Guy Zeltser, reported as Chief Financial Officer of Hippo Holdings Inc. (HIPO), filed a Form 4 disclosing an insider sale on 09/10/2025. The filing shows a disposition of 1,029 shares of Hippo common stock at a price of $36.97 per share (transaction code F). After the sale, the reporting person beneficially owned 80,038 shares in total; the filing specifies that this total includes 65,817 RSUs. The Form 4 was filed by one reporting person and is signed by Guy Zeltser on 09/11/2025.
Richard McCathron, who serves as Chief Executive Officer and a director of Hippo Holdings Inc. (HIPO), reported a sale of 1,358 shares of the company's common stock on 09/10/2025 at a price of $36.97 per share on a Form 4 filing. After the reported sale, his total beneficial ownership is 469,030 shares, which the filing states includes 209,014 restricted stock units (RSUs).
The filing is a routine Section 16 disclosure of an insider disposition and indicates the sale was executed through a reporting process. The report was submitted by an attorney-in-fact on behalf of Mr. McCathron and contains no additional comments about intent, planned future transactions, or derivative positions.
Insider sale by Hippo Holdings CEO and Director. Richard McCathron reported a sale of 2,725 shares of Hippo Holdings Inc. (HIPO) on 09/08/2025 under a Rule 10b5-1 trading plan adopted December 3, 2024. The weighted average sale price was $34.1172, reflecting execution at prices between $34.00 and $34.26. After the sale, the reporting person beneficially owned 470,388 shares, which include 212,464 RSUs. The Form 4 was executed on 09/10/2025 by an attorney-in-fact and discloses the reporting person’s undertaking to provide detailed trade-by-trade pricing upon request.